NAME,INDICATION,TARGET,TARGET LEVEL,CLASS,FAMILY,STATUS,PHASE,CLINICAL STATUS,YEAR OF,DRUG TYPE,MECHANISM OF ACTION
agomelatine,Anti-Depressant,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
agomelatine,Anti-Depressant,5ht2b_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
almotriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2001,small molecule,agonist
almotriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2001,small molecule,agonist
alverine,Antispasmodics,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2014,small molecule,antagonist
amitriptyline,Analgesics,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1961,small molecule,antagonist
aripiprazole,Schizophrenia,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2002,small molecule,partial agonist
aripiprazole,Psychosis,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2015,small molecule,partial agonist
aripiprazole,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2002,small molecule,partial agonist
aripiprazole,Psychosis,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2015,small molecule,partial agonist
asenapine,Schizophrenia,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
asenapine,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
asenapine,Schizophrenia,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
asenapine,Schizophrenia,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
asenapine,Schizophrenia,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
asenapine,Schizophrenia,5ht5a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
asenapine,Schizophrenia,5ht7r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
asenapine,Schizophrenia,5ht2b_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
buspirone,Anti-Anxiety,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1986,small molecule,partial agonist
chlorpromazine,Psychosis,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1957,small molecule,antagonist
chlorprothixene,Schizophrenia,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1967,small molecule,antagonist
chlorprothixene,Schizophrenia,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1967,small molecule,antagonist
chlorprothixene,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1967,small molecule,antagonist
clozapine,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1989,small molecule,antagonist
clozapine,Schizophrenia,5ht1a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1989,small molecule,antagonist
clozapine,Schizophrenia,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1989,small molecule,antagonist
cyproheptadine,Anti-Allergic ; Appetite Stimulant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1961,small molecule,antagonist
doxepin,Hypnotics And Sedatives,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1969,small molecule,antagonist
doxepin,Hypnotics And Sedatives,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1969,small molecule,antagonist
doxepin,Hypnotics And Sedatives,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1969,small molecule,antagonist
eletriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2002,small molecule,agonist
eletriptan,Anti-Migraine,5ht1f_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2002,small molecule,agonist
eletriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2002,small molecule,agonist
ergoloid,Cardiovascular Disease,5ht1a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1953,small molecule,agonist
ergoloid,Cardiovascular Disease,5ht1b_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1953,small molecule,agonist
ergotamine,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1960,small molecule,agonist
ergotamine,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1960,small molecule,agonist
fluoxetine,Autism,5ht2b_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1987,small molecule,antagonist
flupentixol,Antipsychotic,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1965,small molecule,antagonist
frovatriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2001,small molecule,agonist
frovatriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2001,small molecule,agonist
haloperidol,Conduct Disorder,5ht2a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1967,small molecule,antagonist
haloperidol,Psychosis,5ht2a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1986,small molecule,antagonist
levomepromazine,Schizophrenia,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1982,small molecule,antagonist
loxapine,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1975,small molecule,antagonist
loxapine,Psychosis,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1975,small molecule,antagonist
lurasidone,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2010,small molecule,antagonist
lurasidone,Schizophrenia,5ht1a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2010,small molecule,antagonist
lurasidone,Schizophrenia,5ht7r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2010,small molecule,antagonist
methysergide,Anti-Migraine,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
methysergide,Anti-Migraine S; Vasoconstrictor,5ht7r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
methysergide,Anti-Migraine S; Vasoconstrictor,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
methysergide,Anti-Migraine S; Vasoconstrictor,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
methysergide,Anti-Migraine S; Vasoconstrictor,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
metoclopramide,Pregnancy,5ht4r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1979,small molecule,antagonist
mianserin,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
mianserin,Anti-Depressant,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
mirtazapine,Unipolar Depression,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
mirtazapine,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
naratriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1998,small molecule,agonist
naratriptan,Anti-Migraine,5ht1f_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1998,small molecule,agonist
naratriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1998,small molecule,agonist
naratriptan,Anti-Migraine,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1998,small molecule,agonist
nefazodone,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1994,small molecule,antagonist
nefazodone,Unipolar Depression,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1994,small molecule,antagonist
olanzapine,Anti-Depressant,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Schizophrenia,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Anti-Depressant,5ht1a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Anti-Depressant,5ht1b_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Anti-Depressant,5ht1d_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Anti-Depressant,5ht1e_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Anti-Depressant,5ht6r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Anti-Depressant,5ht7r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Schizophrenia,5ht1a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Schizophrenia,5ht1b_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Schizophrenia,5ht1d_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Schizophrenia,5ht1e_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Schizophrenia,5ht6r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
olanzapine,Schizophrenia,5ht7r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1996,small molecule,antagonist
paliperidone,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2006,small molecule,antagonist
pipotiazine,Antipsychotic,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1980,small molecule,antagonist
pipotiazine,Antipsychotic,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1980,small molecule,antagonist
promazine,Antiemetics; Antipsychotic,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1956,small molecule,antagonist
promazine,Antiemetics; Antipsychotic,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1956,small molecule,antagonist
prucalopride,Motilitant,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,agonist
quetiapine,Antipsychotic ; Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1997,small molecule,antagonist
quetiapine,Antipsychotic ; Anti-Depressant,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1997,small molecule,antagonist
risperidone,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1993,small molecule,antagonist
risperidone,Schizophrenia,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1993,small molecule,antagonist
rizatriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1998,small molecule,agonist
rizatriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1998,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2008,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1992,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1f_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2008,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1f_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1992,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2008,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1992,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2008,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1992,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1f_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,agonist
sumatriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,agonist
thioridazine,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
thioridazine,Psychosis,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
tramadol,Analgesics,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1995,small molecule,agonist
tramadol,Analgesics,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,agonist
tramadol,Analgesics,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,recruiting,-,small molecule,agonist
trazodone,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1981,small molecule,partial agonist
trazodone,Anti-Depressant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1981,small molecule,antagonist
trazodone,Anti-Depressant,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1981,small molecule,antagonist
trifluoperazine,Psychosis,5ht2a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1959,small molecule,antagonist
trifluoperazine,Psychosis,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1959,small molecule,antagonist
trimipramine,Unipolar Depression,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1979,small molecule,antagonist
trimipramine,Unipolar Depression,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1979,small molecule,antagonist
vortioxetine,Anti-Depressant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2013,small molecule,agonist
vortioxetine,Anti-Depressant,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2013,small molecule,agonist
vortioxetine,Anti-Depressant,5ht7r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2013,small molecule,agonist
ziprasidone,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2001,small molecule,antagonist
ziprasidone,Schizophrenia,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2001,small molecule,antagonist
zolmitriptan,Anti-Migraine,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1997,small molecule,agonist
zolmitriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1997,small molecule,agonist
zolmitriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1997,small molecule,agonist
zolmitriptan,Anti-Migraine,5ht1f_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1997,small molecule,agonist
zolmitriptan,Anti-Migraine,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,agonist
zolmitriptan,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,agonist
zolmitriptan,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,agonist
zolmitriptan,Anti-Migraine,5ht1f_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,agonist
acepromazine,Antipsychotic,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,-,small molecule,antagonist
acepromazine,Antipsychotic,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,-,small molecule,antagonist
acp-104,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,inverse agonist
am-831,Antipsychotic ; Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,discontinued,-,small molecule,antagonist
am1030,Anti-Inflammatory ; Atopic Dermatitis,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
amap102,Anti-Inflammatory ; Dmard,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
amap102,Anti-Inflammatory ; Dmard,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
apd125,Insomnia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,agonist
apd125,Dementia With Lewy Bodies,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,recruiting,-,small molecule,agonist
apd791,Antithrombotic,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,completed,-,small molecule,agonist
athx-105,Anti-Obesity,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,agonist
ati-7505,Parasympathomimetic,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
ati-9242,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,ongoing,-,small molecule,not available
avn-101,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,completed,-,small molecule,antagonist
avn-211,Schizophrenia,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,unknown,-,small molecule,antagonist
avn-322,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,discontinued,-,small molecule,antagonist
avn-397,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,unknown
bf-1,Anti-Migraine,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,ongoing,-,small molecule,antagonist
bifeprunox,Antipsychotic ; Antiparkinson,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,partial agonist
bifeprunox,Antipsychotic ; Antiparkinson,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,agonist
bifeprunox,Antipsychotic ; Antiparkinson,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,agonist
bifeprunox,Antipsychotic ; Antiparkinson,5ht7r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,agonist
bl-1020,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,terminated,-,small molecule,agonist
brexpiprazole,Anti-Depressant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2015,small molecule,partial agonist
brexpiprazole,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2015,small molecule,partial agonist
brexpiprazole,Anti-Depressant,5ht7r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2015,small molecule,partial agonist
bupropion/trazodone,Anti-Depressant; For Hypoactive Sexual Desire Disorder And Female Sexual Dysfunction,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,partial agonist
bupropion/trazodone,Anti-Depressant; For Hypoactive Sexual Desire Disorder And Female Sexual Dysfunction,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
bupropion/trazodone,Anti-Depressant; For Hypoactive Sexual Desire Disorder And Female Sexual Dysfunction,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
butriptyline,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1974,small molecule,antagonist
bvt.28949,Antiglaucomic,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,unknown,-,small molecule,antagonist
captodiame,Anxiolytic,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,-,small molecule,antagonist
cerlapirdine,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
cinitapride,Gastrointestinal Disorders,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,-,small molecule,antagonist
cinitapride,Gastrointestinal Disorders,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,-,small molecule,agonist
cis-uca eye drops,For Ocular Surface Inflammation,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
cisapride,Parasympathomimetics,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1993,small molecule,agonist
cyclobenzaprine,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1977,small molecule,antagonist
cyclobenzaprine,Muscle Relaxants,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1977,small molecule,antagonist
cyclobenzaprine,Spasticity,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1977,small molecule,antagonist
cyclobenzaprine,"Fibromyalgia, Ptsd",5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,recruiting,-,small molecule,antagonist
dihydroergotamine,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1997,small molecule,agonist
dihydroergotamine,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1997,small molecule,agonist
droperidol,Psychosis,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1970,small molecule,antagonist
eltoprazine,Dyskinesias,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,ongoing,-,small molecule,agonist
eltoprazine,Dyskinesias,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,ongoing,-,small molecule,agonist
eplivanserine,Insomnia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,inverse agonist
eplivanserine,Insomnia,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,inverse agonist
esmirtazapine,Insomnia; Menopausal Symptoms,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,antagonist
esmirtazapine,Insomnia,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,antagonist
fenfluramine,Epilepsy; Dravet'S Syndrome,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,recruiting,-,small molecule,agonist
fenfluramine,Epilepsy; Dravet'S Syndrome,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,recruiting,-,small molecule,agonist
flibanserin,Sexual Dysfunction,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2015,small molecule,agonist
flibanserin,Sexual Dysfunction,5ht2a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2015,small molecule,antagonist
gepirone,Anti-Depressant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,completed,-,small molecule,partial agonist
gsk163090,Unipolar Depression,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
gsk163090,Unipolar Depression,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
gsk163090,Unipolar Depression,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
idalopirdine,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,recruiting,-,small molecule,antagonist
iferanserin,Antihemorrhoidal,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,antagonist
iloperidone,Antipsychotic ; Atypical,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
iloperidone,Antipsychotic ; Atypical,5ht1a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
iloperidone,Antipsychotic ; Atypical,5ht6r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
iloperidone,Antipsychotic ; Atypical,5ht7r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2009,small molecule,antagonist
intepirdine,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,recruiting,-,small molecule,antagonist
iti-007,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,recruiting,-,small molecule,antagonist
lasmiditan,Anti-Migraine,5ht1f_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,ongoing,-,small molecule,agonist
lecozotan,Alzheimer'S Disease,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,antagonist
lisuride,Antiparkinson,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2011,small molecule,agonist
lorcaserin,Anti-Obesity,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2012,small molecule,agonist
lu-ae58054,Schizophrenia,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,ongoing,-,small molecule,antagonist
ly2590443,Anti-Migraine,5ht7r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
mesoridazine,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1970,small molecule,antagonist
methylergonovine,Hemorrhage,5ht2b_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1946,small molecule,partial agonist
mg01ci,Neurologic Disorders; Adhd,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,terminated,-,small molecule,antagonist
min-001,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
min-117,Anti-Depressant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
min-117,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
minaprine,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,withdrawn,1984,small molecule,antagonist
minaprine,Anti-Depressant,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,withdrawn,1984,small molecule,antagonist
minaprine,Anti-Depressant,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,withdrawn,1984,small molecule,antagonist
mn-305,Anti-Depressant; Hypnotic,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,agonist
molindone,Schizophrenia,5ht2a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1974,small molecule,antagonist
mosapride,Gastrointestinal Reflux Disease (Gerd),5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,recruiting,-,small molecule,agonist
naronapride,Constipation,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
nelotanserin,Dementia; Parkinson'S Disease,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,recruiting,-,small molecule,inverse agonist
nemifitide,Anti-Depressant,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,peptide,antagonist
nxn-188,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
nxn-188,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
opc-14523,Anti-Depressant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
pardoprunox,Antiparkinson,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,agonist
pardoprunox,Antiparkinson,5ht7r_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,agonist
pf-05212377,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,terminated,-,small molecule,antagonist
piclozotan,Stroke,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,agonist
pimavanserin,Antiparkinson,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2016,small molecule,inverse agonist
propiomazine,Hypnotics And Sedatives,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1960,small molecule,antagonist
propiomazine,Hypnotics And Sedatives,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1960,small molecule,antagonist
prx-00023,Anti-Depressant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,agonist
prx-07034,Anti-Obesity ; Nootropic,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,completed,-,small molecule,antagonist
prx-08066,Antihypertensive,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
prx-3140,Alzheimer'S Disease,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
psn602,Anti-Obesity,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,discontinued,-,small molecule,agonist
renzapride,Irritable Bowel Syndrome,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,agonist
renzapride,Irritable Bowel Syndrome,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,antagonist
renzapride,Irritable Bowel Syndrome,5ht2a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,antagonist
renzapride,Irritable Bowel Syndrome,5ht2c_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,antagonist
rvt-101,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,ongoing,-,small molecule,antagonist
SEP-363856,Antiparkinson; Schizophrenia; Psychosis,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
sertindole,Schizophrenia,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,withdrawn,3,recruiting,1998,small molecule,antagonist
sertindole,Schizophrenia,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,withdrawn,3,recruiting,1998,small molecule,inverse agonist
sertindole,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,withdrawn,3,recruiting,1998,small molecule,antagonist
SL 650472,Intermittent Claudication,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
SL 650472,Intermittent Claudication,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
suvn-502,Alzheimer'S Disease,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,recruiting,-,small molecule,antagonist
suvn-d4010,Alzheimer'S Disease,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,recruiting,-,small molecule,agonist
syn120,Cognitive Disorders,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
syn120,Cognitive Disorders,5ht6r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,antagonist
td-2749,Motilitant,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,discontinued,-,unknown,agonist
tedatioxetine,Anti-Depressant,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
tegaserod,Motilitant,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2002,small molecule,partial agonist
temanogrel,Acute Coronary Syndrome,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,unknown,-,small molecule,inverse agonist
terguride,"Diffuse Cutaneous Systemic Sclerosis, Antihypertensive",5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,ongoing,-,small molecule,antagonist
terguride,"Diffuse Cutaneous Systemic Sclerosis, Antihypertensive",5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,ongoing,-,small molecule,antagonist
thiethylperazine,Antiemetics,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1961,small molecule,antagonist
thiethylperazine,Antiemetics,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1961,small molecule,antagonist
thioproperazine,Antipsychotic,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
thioproperazine,Antipsychotic,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1962,small molecule,antagonist
thiothixene,Psychosis,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1967,small molecule,antagonist
tonabersat,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,antagonist
triflupromazine,Antiemetics; Antipsychotic,5ht2b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,1957,small molecule,antagonist
vabicaserin,Schizophrenia,5ht2c_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,agonist
vabicaserin,Schizophrenia,5ht2a_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,agonist
vabicaserin,Schizophrenia,5ht2b_human ,secondary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,discontinued,-,small molecule,agonist
velusetrag,Motilitant,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,ongoing,-,small molecule,agonist
vilazodone,Anti-Depressant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,approved,4,-,2011,small molecule,agonist
volinanserin,Hypnotics And Sedatives,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,antagonist
vr-147,Anti-Migraine,5ht1b_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,discontinued,-,small molecule,not available
vr-147,Anti-Migraine,5ht1d_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,1,discontinued,-,small molecule,not available
xaliproden,Neuroprotectant,5ht1a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,3,discontinued,-,small molecule,agonist
ykp-1358,Schizophrenia,5ht2a_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,unknown,antagonist
ykp10811,For Chronic Or Functional Constipation,5ht4r_human ,primary,A (Rhodopsin),5-Hydroxytryptamine receptors,in trial,2,completed,-,small molecule,agonist
